Apolipoprotein C3

From Wikipedia, the free encyclopedia

  (Redirected from ApoCIII)
Jump to: navigation, search
edit
Apolipoprotein C-III
Identifiers
Symbols APOC3; APOCIII; MGC150353
External IDs OMIM107720 MGI88055 HomoloGene81615 GeneCards: APOC3 Gene
RNA expression pattern
PBB GE APOC3 205820 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 345 11814
Ensembl ENSG00000110245 ENSMUSG00000032081
UniProt P02656 P33622
RefSeq (mRNA) NM_000040 NM_023114
RefSeq (protein) NP_000031 NP_075603
Location (UCSC) Chr 11:
116.21 - 116.21 Mb
Chr 9:
45.98 - 45.99 Mb
PubMed search [1] [2]

Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to inhibit hepatic uptake [1] of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia.

Contents

[edit] See also

Lately, two novel susceptibility haplotypes i.e. P2-S2-X1 and P1-S2-X1 have been discovered in ApoAI-CIII-AIV gene cluster on chromosme 11q23, who confer approximately threefold higher risk of coronary heart disease in normal [2] as well as non-insulin diabetes mellitus.[3]

[edit] External links

[edit] References

  1. ^ Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM (2009). "Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins". Arteriosclerosis, Thrombosis and Vascular Biology. PMID 19910636. 
  2. ^ Singh PP, Singh M, Kaur TP, Grewal SS (2007). "A novel haplotype in ApoAI-CIII-AIV gene region is detrimental to Northwest Indians with coronary heart disease". Int J Cardiol 130 (3): e93–5. doi:10.1016/j.ijcard.2007.07.029. PMID 17825930. 
  3. ^ Singh PP, Singh M, Gaur S, Grewal SS (2007). "The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype.". Diab Vasc Dis Res 4 (2): 124–29. doi:10.3132/dvdr.2007.030. PMID 17654446. 

[edit] Further reading

Languages